Yale Pharmaceutical Research Institute Inc is categorized under Commercial Medical Research in Gaithersburg, MD and active since 1996.
Yale Pharmaceutical Research Institute Inc was established in 1996, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Robert Golden at the company’s single location by writing to 525 Skidmore Boulevard, Gaithersburg, Maryland MD 20877 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Yale Pharmaceutical Research Institute Inc |
Contact Person: | Robert Golden |
Address: | 525 Skidmore Boulevard, Gaithersburg, Maryland 20877 |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 1996 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Commercial Medical Research |
SIC Code: | 8731 |
NAICS Code: | 541712 |
Share This Business: |
Yale Pharmaceutical Research Institute Inc was started in 1996 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Robert Golden for inquiries that concern Yale Pharmaceutical Research Institute Inc by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Yale Pharmaceutical Research Institute Inc can be found at the coordinates as well as the street address 525 Skidmore Boulevard in Gaithersburg, Maryland 20877.
For its online presence, you may visit Yale Pharmaceutical Research Institute Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.